The trademark application EXART was filed by Maddox Pharma Swiss B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on October 8, 2023, and it was registered by office on January 15, 2024 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Pharmaceutical preparations and substances
Pharmaceutical preparations for the treatment and/or prevention of hypertension
Pharmaceutical preparations for the treatment of cardiovascular diseases
Cardiovascular drugs for use in treating hypertension.